1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Brain Infarction in 1 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
Brain Infarction: Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Perry, T | 1 |
| Kindy, MS | 1 |
| Harvey, BK | 1 |
| Tweedie, D | 1 |
| Holloway, HW | 1 |
| Powers, K | 1 |
| Shen, H | 1 |
| Egan, JM | 1 |
| Sambamurti, K | 1 |
| Brossi, A | 1 |
| Lahiri, DK | 1 |
| Mattson, MP | 1 |
| Hoffer, BJ | 1 |
| Wang, Y | 1 |
| Greig, NH | 1 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Brain Infarction
| Article | Year |
|---|---|
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Infarction; Cell Death; Cell Hypoxia; C | 2009 |